-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
China Pharma Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- China Pharma Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $1.62M, a 20.5% decline year-over-year.
- China Pharma Holdings, Inc. annual Cost of Revenue for 2023 was $7.29M, a 15.2% decline from 2022.
- China Pharma Holdings, Inc. annual Cost of Revenue for 2022 was $8.6M, a 7.48% decline from 2021.
- China Pharma Holdings, Inc. annual Cost of Revenue for 2021 was $9.29M, a 4.25% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)